Vyasa is privately funded and the company started with an initial round of $500,000. The company is projecting over $3 million in revenues this year with about a 30-40 percent margin.

Vyasa will be showcasing its full suite of deep learning applications, including Cortex, as part of the Dell Technologies booth (#2000) at the 2022 HIMSS Global Health Conference & Exhibition.

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief ...

In Vyasa Dhanurveda, Shiva is not ranked as an archer in the traditional sense. He is not part of the competition between mortal men, as his existence transcends the need for archery.

BOSTON, March 10, 2022 — Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest ...

Today Vyasa Analytics, announced it has joined the NVIDIA Inception program, which is designed to nurture startups revolutionizing industries with advancements in AI and data sciences. Vyasa is a deep ...